https://www.bmsstudyconnect.com/ca/en/clinical-trials/NCT06730750.html
A Study of BMS-986490 With or Without Bevacizumab in Advanced Solid Tumors | BMS Study Connect
This is a study of BMS-986490 as a monotherapy and in combination with bevacizumab in participants with select advanced solid tumors known to express CEACAM5.